Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, May 2026, Jun 2026 and Jul 2026.
- Largest single sale: $2.7M (75,117 shares) of NewAmsterdam Pharma Co N.V. on Dec 23, 2025. Filing
- Last sale before this period: Sep 9, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | Chief Accounting Officer | Dec 29, 2023 | Jul 22, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 20, 2026, NewAmsterdam Pharma Co N.V.: sold 105,000 shares for $3.2M, under a disclosed plan; 105,000 shares acquired by exercising options. 1 filing: 1
- Jun 22, 2026, NewAmsterdam Pharma Co N.V.: sold 40,000 shares for $1.2M, under a disclosed plan; 40,000 shares acquired by exercising options. 1 filing: 1
- May 26, 2026, NewAmsterdam Pharma Co N.V.: sold 65,000 shares for $2.3M, under a disclosed plan; 65,000 shares acquired by exercising options. 1 filing: 1
- Jan 28, 2026, NewAmsterdam Pharma Co N.V.: sold 32,612 shares for $1.0M, under a disclosed plan; 32,612 shares acquired by exercising options. 1 filing: 1
- Jan 27, 2026, NewAmsterdam Pharma Co N.V.: sold 39,816 shares for $1.3M, under a disclosed plan; 39,816 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.